Keyphrases
Starch
100%
Polycaprolactone
100%
Microparticles
100%
Bone Morphogenetic protein-2 (BMP-2)
100%
Osteogenesis
18%
Growth Factors
9%
Enzyme-linked Immunosorbent Assay (ELISA)
9%
Alkaline Phosphatase
9%
Sustained Release
9%
Controlled Release
9%
Drug Delivery System
9%
Burst Release
9%
Activity Level
9%
C2C12 Cells
9%
Luciferase Assay
9%
Promoter Activity
9%
Alkaline Phosphatase Activity
9%
Osteocalcin
9%
Encapsulation Efficiency
9%
Collagen Matrix
9%
Osteogenic Potential
9%
Osteogenic Activity
9%
Human Adipose-derived Stem Cells (hADSCs)
9%
Osteo
9%
In Vitro Release Profile
9%
C2C12
9%
Osteogenic Induction
9%
Myoblast Cells
9%
Injectable Drug Delivery
9%
Induction Agents
9%
Pharmacology, Toxicology and Pharmaceutical Science
Microparticle
100%
Bone Morphogenetic Protein 2
100%
Polycaprolactone
100%
Alkaline Phosphatase
18%
Dexamethasone
18%
Growth Factor
9%
Enzyme-Linked Immunosorbent Assay
9%
Drug Delivery System
9%
Sustained Release
9%
Controlled Release
9%
Glucocorticoid
9%
Luciferase
9%
Osteocalcin
9%
Biochemistry, Genetics and Molecular Biology
Starch
100%
Bone Morphogenetic Protein 2
100%
Bone Development
18%
C2C12
18%
Alkaline Phosphatase
18%
Dexamethasone
18%
In Vitro Release
9%
Enzyme
9%
Promoter Region
9%
Stem Cell
9%
Mineralization
9%
Sustained Drug Release
9%
Luciferase
9%
Growth Factor
9%
Osteocalcin
9%
Glucocorticoid
9%